VK

Vivek Kumar

Active Director Director DIN 10203221
DIN 10203221 First appointment Jun 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Vivek Kumar

Data last updated:

Vivek Kumar is a Director at Vvs Meditech Private Limited (since 2023). Vvs Meditech Private Limited reported revenue of ₹59 Lakh (FY 2024).

DIN 10203221
Primary Designation Director
First Appointment 12 Jun 2023
Oldest Company Age 3 yrs
Largest company Vvs Meditech Private Limited · ₹59 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vvs Meditech Private Limited U46596JH2023PTC020710
Director12 Jun 20232023₹59 Lakh (FY 2024)Active

Board colleagues of Vivek Kumar

NameDINCompanyDesignation
Seema Agrawal02438526Vvs Meditech Private LimitedDirector
Supriya Kumari10203222Vvs Meditech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vvs Meditech Private Limited
Premium access

Shareholding and investment profile for Vivek Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Kumar

Vivek Kumar currently holds 1 directorship: Vvs Meditech Private Limited (Director, since 12 Jun 2023, revenue ₹59 Lakh (FY 2024)).

Vivek Kumar was first appointed on 12 Jun 2023 as Director at Vvs Meditech Private Limited.

The current boards of Vivek Kumar's companies include Seema Agrawal (Vvs Meditech Private Limited), Supriya Kumari (Vvs Meditech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available